What is it about?
A modified Risk Assessment Score of PAH (mRASP) comprising four non-invasive variables which were World Health Organization functional class(WHO FC), 6-minute walk distance (6MWD),N-terminal of the pro-hormone brain natriuretic peptide(NT-pro BNP), and right atrial area(RAA) could be eligible risk assessment tool for the prognostic assessment of PAH.
Featured Image
Why is it important?
It could be more convenient for clinicians to perform assessment of patients with PAH in primary settings.
Perspectives
It could contribute some inspiration to researchers to find more convenient and less invasive approach for assessment of patients with PH.
Dr Wei Xiong
Xinhua Hospital Affiliated to Shanghai Jiaotong University School of Medicine
Read the Original
This page is a summary of: A modified risk score in one-year survival rate assessment of group 1 pulmonary arterial hypertension, BMC Pulmonary Medicine, October 2018, Springer Science + Business Media,
DOI: 10.1186/s12890-018-0712-7.
You can read the full text:
Contributors
The following have contributed to this page
